All programs in our pipeline are solely owned by Modulus, and we are open for any partnering and collaboration opportunities.

Although our pipeline is enriched in specific therapeutic areas, we are open to considering a wide range of drug discovery and technology collaborations regardless of disease area or technologies.

Please contact us /contact-us for inquiries regarding our discovery programs.